MedPath
Found 2 clinical trials|View Analysis
Sort by:

Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA

Phase 2
Recruiting
Conditions
Warm Autoimmune Hemolytic Anemia
Interventions
First Posted Date
2023-06-28
Last Posted Date
2024-04-26
Lead Sponsor
Chen Miao
Target Recruit Count
22
Registration Number
NCT05922839
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, Beijing, China

The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.

Not Applicable
Completed
Conditions
Heart Rate Variability
Anxiety
Blood Pressure
Eye Movement Desensitization and Reprocessing Intervention
Interventions
Behavioral: Eye Movement Desensitization and Reprocessing
First Posted Date
2023-05-01
Last Posted Date
2023-05-01
Lead Sponsor
Miao-Yi Chen
Target Recruit Count
110
Registration Number
NCT05836181
Locations
🇨🇳

Chen, miao-yi, Taipei, Neihu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath